China, Aug. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Qualitative study protocol of the experience of immune related adverse events in patients with malignancy'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130788
Registration Time: 2026/08/25
Type: Observational study
Primary Sponsor: The First Affiliated Hospital of Zhengzhou University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=248979
Published by HT Digital Content Services with permission from Health Daily Digest....